Innovative Precision Medicine Platform Sano Genetics’ integrated platform that combines genetic testing, recruitment, and engagement presents a compelling solution for research institutions and biotech companies aiming to streamline patient enrollment and data management in precision medicine projects.

Strong Financial Support With over 15 million dollars in funding, including recent Series A investment led by Plural, Sano Genetics demonstrates substantial investor confidence, enabling expansion into new markets and development of advanced genetic research tools.

Recent Strategic Collaborations Partnerships such as with Neuron23TM Inc. for facilitating subject referrals highlight opportunities for sales in clinical trial recruitment and patient engagement solutions targeted at biotech and pharmaceutical companies.

Focus on Neurology & Rare Diseases The launch of the Light the Way platform for motor neurone disease and recruitment of neurology experts like VP of Neuroscience suggests a targeted approach toward neurological disorder research and associated genetic testing services, opening avenues for specialized offerings.

Growing Market Presence With a recent funding round, expanding team, and high-profile partnerships, Sano Genetics is positioning itself as a leader in the precision medicine ecosystem, making it a promising prospect for sales of genetic data solutions, software integrations, and research collaboration services.